Recently there is a case report published utilizing antagonist of interleukin-4 receptor alpha for a patient who is treatment-resistant to other typical treatment options for exfoliative cheilitis, namely topical corticosteroids, topical tacrolimus, petroleum jelly, and doxycycline. Dupilumab, a human monoclonal antibody, functions as an antagonist for the interleukin-4 (IL-4) receptor alpha. By doing so, it… Continue reading Case report of treating exfoliative cheilitis with interleukin-4 (IL-4) receptor alpha antagonist